NCT04193852View on ClinicalTrials.gov

Bioavailability of Dienogest and Ethinyl Estradiol Tablets 2.0 mg/0.03 mg With Regards to Reference Product

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

November 9, 2019

Primary Completion Date

November 12, 2019

Study Completion Date

November 25, 2019

Conditions
Bioequivalence
Interventions
DRUG

Dienogest 2.0 mg and Ethinyl estradiol 0.03 mg Test Drug

Coated Tablets

DRUG

Dienogest 2.0 mg and Ethinyl estradiol 0.03 mg Reference Product

Coated Tablets

Trial Locations (1)

7510491

Innolab, Santiago

Sponsors
All Listed Sponsors
lead

Laboratorios Andromaco S.A.

INDUSTRY

NCT04193852 - Bioavailability of Dienogest and Ethinyl Estradiol Tablets 2.0 mg/0.03 mg With Regards to Reference Product | Biotech Hunter | Biotech Hunter